Canlyniadau Chwilio - David Hilton‐Jones

Mireinio'r Canlyniadau
  1. 1
    International Workshop on Inclusion Body Myositis held at the Institute of Myology, Paris, on 29 May 2009

    International Workshop on Inclusion Body Myositis held at the Institute of Myology, Paris, on 29 May 2009 gan Olivier Benvéniste, David Hilton‐Jones

    Cyhoeddwyd 2010
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    The myotonic dystrophies: diagnosis and management

    The myotonic dystrophies: diagnosis and management gan C Turner, David Hilton‐Jones

    Cyhoeddwyd 2010
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    Diagnostic criteria for inclusion body myositis

    Diagnostic criteria for inclusion body myositis gan David Hilton‐Jones, Stefen Brady

    Cyhoeddwyd 2016
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Spontaneous intracranial hypotension.

    Spontaneous intracranial hypotension. gan Shelley Renowden, Ralph Gregory, N. Hyman, David Hilton‐Jones

    Cyhoeddwyd 1995
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    Motor neuron disease in England and Wales, 1959-1979.

    Motor neuron disease in England and Wales, 1959-1979. gan Jonathan Buckley, C Warlow, Peter G. Smith, David Hilton‐Jones, S Irvine, John Tew

    Cyhoeddwyd 1983
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    Human disease caused by loss of fast IIa myosin heavy chain due to recessive MYH2 mutations

    Human disease caused by loss of fast IIa myosin heavy chain due to recessive MYH2 mutations gan Homa Tajsharghi, David Hilton‐Jones, Olayinka Raheem, Anna Maija Saukkonen, Anders Oldfors, Bjarne Udd

    Cyhoeddwyd 2010
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    A retrospective cohort study identifying the principal pathological features useful in the diagnosis of inclusion body myositis

    A retrospective cohort study identifying the principal pathological features useful in the diagnosis of inclusion body myositis gan Stefen Brady, Waney Squier, C. Sewry, Michael G. Hanna, David Hilton‐Jones, Janice L. Holton

    Cyhoeddwyd 2014
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    Myasthenia gravis: Association of British Neurologists’ management guidelines

    Myasthenia gravis: Association of British Neurologists’ management guidelines gan Jon Sussman, Maria Elena Farrugia, Paul Maddison, Marguerite Hill, Maria Isabel Leite, David Hilton‐Jones

    Cyhoeddwyd 2015
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    Amyloid deposits and inflammatory infiltrates in sporadic inclusion body myositis: the inflammatory egg comes before the degenerative chicken

    Amyloid deposits and inflammatory infiltrates in sporadic inclusion body myositis: the inflammatory egg comes before the degenerative chicken gan Olivier Benvéniste, Werner Stenzel, David Hilton‐Jones, Marco Sandri, Olivier Boyer, Baziel G.M. van Engelen

    Cyhoeddwyd 2015
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    Comparison of the relative levels of the 3243 (A-->G) mtDNA mutation in heteroplasmic adult and fetal tissues.

    Comparison of the relative levels of the 3243 (A-->G) mtDNA mutation in heteroplasmic adult and fetal tissues. gan Paul M. Matthews, Julian M. Hopkin, R. M. Brown, J Stephenson, David Hilton‐Jones, Garry K. Brown

    Cyhoeddwyd 1994
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    The use of rituximab in myasthenia gravis and Lambert-Eaton myasthenic syndrome

    The use of rituximab in myasthenia gravis and Lambert-Eaton myasthenic syndrome gan Peter J. Maddison, J. McConville, Maria Elena Farrugia, Nigel P. Davies, Michael R. Rose, F. Norwood, Heinz Jungbluth, S. Robb, David Hilton‐Jones

    Cyhoeddwyd 2010
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    The need for biochemical testing in beta‐enolase deficiency in the genomic era

    The need for biochemical testing in beta‐enolase deficiency in the genomic era gan Ralph Wigley, R. Scalco, A. Gardiner, Richard Godfrey, Suzanne Booth, Richard Kirk, David Hilton‐Jones, Henry Houlden, Simon Heales, Rosaline C. M. Quinlivan

    Cyhoeddwyd 2019
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    Guidelines for treatment of autoimmune neuromuscular transmission disorders

    Guidelines for treatment of autoimmune neuromuscular transmission disorders gan Geir Skeie, Slobodan Apostolski, Amelia Evoli, Nils Erik Gilhus, Isabel Illa, Lutz Harms, David Hilton‐Jones, Arthur Melms, Jan J.G.M. Verschuuren, H. W. Horge

    Cyhoeddwyd 2010
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  14. 14
    Long-term observational study of sporadic inclusion body myositis

    Long-term observational study of sporadic inclusion body myositis gan Olivier Benvéniste, Marguerite Guiguet, John Freebody, O. Dubourg, Waney Squier, Thierry Maisonobe, Tanya Stojkovic, Maria Isabel Leite, Yves Allenbach, S. Herson, Stefen Brady, B. Eymard, David Hilton‐Jones

    Cyhoeddwyd 2011
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  15. 15
    Guidelines for the treatment of autoimmune neuromuscular transmission disorders

    Guidelines for the treatment of autoimmune neuromuscular transmission disorders gan Geir Skeie, Slobodan Apostolski, Amelia Evoli, Nils Erik Gilhus, I. K. Hart, Lutz Harms, David Hilton‐Jones, Arthur Melms, Jan J.G.M. Verschuuren, H. W. Horge

    Cyhoeddwyd 2006
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  16. 16
    Clinical Features and Diagnostic Usefulness of Antibodies to Clustered Acetylcholine Receptors in the Diagnosis of Seronegative Myasthenia Gravis

    Clinical Features and Diagnostic Usefulness of Antibodies to Clustered Acetylcholine Receptors in the Diagnosis of Seronegative Myasthenia Gravis gan Pedro M. Rodríguez Cruz, Michal Al-Hajjar, Saif Huda, Leslie Jacobson, Mark Woodhall, Sandeep Jayawant, Camilla Buckley, David Hilton‐Jones, David Beeson, Angela Vincent, Maria Isabel Leite, Jacqueline Palace

    Cyhoeddwyd 2015
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  17. 17
    IgG-specific cell-based assay detects potentially pathogenic MuSK-Abs in seronegative MG

    IgG-specific cell-based assay detects potentially pathogenic MuSK-Abs in seronegative MG gan Saif Huda, Patrick Waters, Mark Woodhall, Maria Isabel Leite, Leslie Jacobson, Anna De Rosa, Michelangelo Maestri, Roberta Ricciardi, Jeannine M. Heckmann, Angelina Maniaol, Amelia Evoli, Judy Cossins, David Hilton‐Jones, Angela Vincent

    Cyhoeddwyd 2017
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  18. 18
    Genotype/phenotype correlations in AARS-related neuropathy in a cohort of patients from the United Kingdom and Ireland

    Genotype/phenotype correlations in AARS-related neuropathy in a cohort of patients from the United Kingdom and Ireland gan Boglárka Bánsági, Thalia Antoniadi, Sarah Burton‐Jones, Sinéad M. Murphy, John C. McHugh, Michael Alexander, Richard A. Wells, Joanna P. Davies, David Hilton‐Jones, Hanns Lochmüller, Patrick F. Chinnery, Rita Horváth

    Cyhoeddwyd 2015
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  19. 19
    Chronic pain has a strong impact on quality of life in facioscapulohumeral muscular dystrophy

    Chronic pain has a strong impact on quality of life in facioscapulohumeral muscular dystrophy gan Germán Morís, Libby Wood, Roberto Fernández‐Torrón, José Andrés González Coraspe, Chris Turner, David Hilton‐Jones, Fiona Norwood, Tracey Willis, Matt Parton, Mark Rogers, Simon Hammans, Mark Roberts, Elizabeth Househam, Maggie Williams, Hanns Lochmüller, Teresinha Evangelista

    Cyhoeddwyd 2017
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  20. 20
    Mortality and Causes of Death in Patients with Sporadic Inclusion Body Myositis: Survey Study Based on the Clinical Experience of Specialists in Australia, Europe and the USA

    Mortality and Causes of Death in Patients with Sporadic Inclusion Body Myositis: Survey Study Based on the Clinical Experience of Specialists in Australia, Europe and the USA gan Mark Price, Victoria Barghout, Olivier Benvéniste, Lisa Christopher‐Stine, Alastair Corbett, Marjolein Visser, David Hilton‐Jones, John T. Kissel, Thomas E. Lloyd, Ingrid E. Lundberg, Francis Mastaglia, Tahseen Mozaffar, Merrilee Needham, Jens Schmidt, Kumaraswamy Sivakumar, Carla DeMuro, Brian S. Tseng

    Cyhoeddwyd 2016
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: